中芯(00981.HK)提升今年資本開支目標至67億美元 料毛利率高於去年
中芯(00981.HK)首席財務官高永崗於電話會上表示,今年資本開支自早前預期的43億美元提升至67億美元,主要用於先進工業的產能建設及成熟工業的產能擴展,至於北京項目僅在籌劃階段,因此並未納入是次資本開資提升。
公司並預期,全年收入將錄得中至高十位數收入增長,料毛利率將高於去年,EBITDA料錄得18億美元。
中芯董事長周子學表示,上半年新型肺炎對全球經濟及半導體行業造成影響,惟業務仍造好及創新高。料未來宏觀環境仍複雜,公司將繼續豐富產品平台及拓展海內外市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.